SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-19-000010
Filing Date
2019-08-08
Accepted
2019-08-08 11:46:20
Documents
76
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20190630x10q.htm 10-Q 1518666
2 EX-31.1 veru-20190630xex31_1.htm EX-31.1 15676
3 EX-31.2 veru-20190630xex31_2.htm EX-31.2 15848
4 EX-32.1 veru-20190630xex32_1.htm EX-32.1 11457
  Complete submission text file 0000863894-19-000010.txt   7301445

Data Files

Seq Description Document Type Size
5 EX-101.INS veru-20190630.xml EX-101.INS 1734448
6 EX-101.SCH veru-20190630.xsd EX-101.SCH 57222
7 EX-101.CAL veru-20190630_cal.xml EX-101.CAL 53489
8 EX-101.DEF veru-20190630_def.xml EX-101.DEF 201391
9 EX-101.LAB veru-20190630_lab.xml EX-101.LAB 432222
10 EX-101.PRE veru-20190630_pre.xml EX-101.PRE 371984
Mailing Address 4400 BISCAYNE BOULEVARD SUITE 888 MIAMI FL 33137
Business Address 4400 BISCAYNE BOULEVARD STE 888 MIAMI FL 33137 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 191008300
SIC: 2834 Pharmaceutical Preparations